Interview with MEP Stine Bosse: “Now or never” for Europe’s biotech

EU PERSPECTIVES - Europe may be running out of time to protect one of its last global tech advantages. If we fail, biotech could become the next chapter in the story of missed opportunities: "Defence, we lost. Digital, we also lost," says MEP Stine Bosse. "The price of our patients' life-saving medicines cannot be set in the White House," she stresses in an exclusive interview with EU Perspectives. Read more

MEP Stine Bosse (Renew, DK) is pushing to embed a "28th regime" for rare diseases into the EU's Biotech Act Picture: European Parliament